Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Paula M. Fracasso, MD, PhD
Washington University Siteman Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Ccop - Western Regional, Arizona
Phoenix, Arizona, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
Orange, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado, United States
- New Britain General Hospital
New Britain, Connecticut, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Mbccop - University of Illinois at Chicago
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Saint Joseph Regional Medical Center
South Bend, Indiana, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Ellis Fischel Cancer Center at University of Missouri - Columbia
Columbia, Missouri, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Ccop - Cancer Research for the Ozarks
Springfield, Missouri, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Suny Downstate Medical Center
Brooklyn, New York, United States
- Long Island Cancer Center at Stony Brook University Hospital
Stony Brook, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Mount Carmel West Hospital
Columbus, Ohio, United States
- University of Oklahoma College of Medicine
Oklahoma City, Oklahoma, United States
- Ccop - Columbia River Oncology Program
Portland, Oregon, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
- Penn State Cancer Institute at Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States
- Southeast Gynecologic Oncology Associates
Knoxville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
Nashville, Tennessee, United States
- Ccop - Scott and White Hospital
Temple, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 1999
- Primary completion
- —
- Completion
- 30 Sept 2007
- Last update posted
- 24 Jun 2013
- Registered enrollment
- —
- Registry id
- NCT00071929
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.